Abstract
Background Occurrence of thrombotic disease after orthopedic surgery has always been an important issue affecting the prognosis of patients. In this paper, retrospective analysis was used to analyze the D-dimer clearance rate after different degrees of fractures, suggesting that the D-dimer clearance rate can be used as an index to evaluate thrombotic diseases after orthopedic surgery.
Material/Methods Seventy-five patients with orthopedic surgery were randomly selected from March to June 2017. According to the degrees of fractures and complications, they were divided into SF(single fracture), MF(multiple fracture), FCI(Fracture combined with infection)three groups, 25 in each group.D-dimer results of each case on 1 day, 2 days, 3 days, 4 days, 5 days, and 7 days after orthopedic surgery were recorded and counted.The slope of correlation equation of D-dimer value according to time is the D-dimer clearance rate.
Results The D-dimer clearance rate in the SF□JMF □FCI group was −0.0490, −0.0502 and −0.0692□The P value is respectively 0.0049, 0.0061 and 0.0163, the difference is significant.
Conclusions After traumatic fracture surgery, whether D-dimer clears at a normal rate is closely related to its outcome. Decreasing D-dimer clearance is related to postoperative infections and thrombotic diseases. D-dimer clearance can be used as an important parameter and observation index for judging the clinical outcome of patients with complications such as severe trauma and infection. At the same time, we can further study the cut-off value of D-dimer clearance.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This study was registered with a clinical institution and received an ethical review. Ethical certification documents are attached to the supplementary documents.
Funding Statement
Capital Characteristic Clinical Application Research Fund(CN) Award Number:12017B3003
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All relevant data are within the paper and its Supporting Information files.